May. 18 at 4:23 PM
$MODD I’m not blaming anyone because everyone is trying, and some things are just not controllable, like shutdowns, the FDA pace, and a terrible market environment. Question is: what to do right now? We don’t have all the info: has anyone enquired (in a serious way) about a buyout or partnership? Has the search been extended more broadly, ie overseas companies, pen makers, CGM companies, private equity, etc? Also, the GLP-1 infusion idea seems to have vanished.
If no one is interested, and Modular developed an FDA-approved product no one wants, that will have been very unfortunate, which raises questions about why the company proceeded down this path.
